| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.05 |